| Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 … C Allemani, T Matsuda, V Di Carlo, R Harewood, M Matz, M Nikšić, ... The Lancet 391 (10125), 1023-1075, 2018 | 4426 | 2018 |
| Projections of the cost of cancer care in the United States: 2010–2020 AB Mariotto, K Robin Yabroff, Y Shao, EJ Feuer, ML Brown Journal of the National Cancer Institute 103 (2), 117-128, 2011 | 3037 | 2011 |
| Annual report to the nation on the status of cancer, 1975–2014, featuring survival A Jemal, EM Ward, CJ Johnson, KA Cronin, J Ma, AB Ryerson, A Mariotto, ... JNCI: Journal of the National Cancer Institute 109 (9), djx030, 2017 | 1584 | 2017 |
| SEER cancer statistics review, 1975-2011, national cancer institute N Howlader, AM Noone, M Krapcho, J Garshell, D Miller, SF Altekruse, ... Bethesda, MD 86, 2014 | 1380* | 2014 |
| Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or … BK Edwards, AM Noone, AB Mariotto, EP Simard, FP Boscoe, SJ Henley, ... Cancer 120 (9), 1290-1314, 2014 | 1367 | 2014 |
| The Effect of Advances in Lung-Cancer Treatment on Population Mortality N Howlader, G Forjaz, MJ Mooradian, R Meza, CY Kong, KA Cronin, ... New England Journal of Medicine 383 (7), 640-649, 2020 | 1130 | 2020 |
| Anticipating the “silver tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States SM Bluethmann, AB Mariotto, JH Rowland Cancer Epidemiology and Prevention Biomarkers 25 (7), 1029-1036, 2016 | 997 | 2016 |
| Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context G Draisma, R Etzioni, A Tsodikov, A Mariotto, E Wever, R Gulati, E Feuer, ... Journal of the National Cancer Institute 101 (6), 374-383, 2009 | 996 | 2009 |
| SEER Cancer Statistics Review, 1975–2013. Bethesda, MD: National Cancer Institute; 2016 N Howlader, AM Noone, M Krapcho, D Miller, K Bishop, SF Altekruse, ... | 957* | 2016 |
| Cost of care for elderly cancer patients in the United States KR Yabroff, EB Lamont, A Mariotto, JL Warren, M Topor, A Meekins, ... Journal of the National Cancer Institute 100 (9), 630-641, 2008 | 774 | 2008 |
| Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care JS De Moor, AB Mariotto, C Parry, CM Alfano, L Padgett, EE Kent, ... Cancer Epidemiology and Prevention Biomarkers 22 (4), 561-570, 2013 | 752 | 2013 |
| Economic burden of cancer in the United States: estimates, projections, and future research KR Yabroff, J Lund, D Kepka, A Mariotto Cancer Epidemiology and Prevention Biomarkers 20 (10), 2006-2014, 2011 | 615 | 2011 |
| Survivors of childhood cancer in the United States: prevalence and burden of morbidity SM Phillips, LS Padgett, WM Leisenring, KK Stratton, K Bishop, KR Krull, ... Cancer Epidemiology and Prevention Biomarkers 24 (4), 653-663, 2015 | 559 | 2015 |
| Adverse events after outpatient colonoscopy in the Medicare population JL Warren, CN Klabunde, AB Mariotto, A Meekins, M Topor, ML Brown, ... Annals of internal medicine 150 (12), 849-857, 2009 | 544 | 2009 |
| Quantifying the role of PSA screening in the US prostate cancer mortality decline R Etzioni, A Tsodikov, A Mariotto, A Szabo, S Falcon, J Wegelin, ... Cancer Causes & Control 19 (2), 175-181, 2008 | 503 | 2008 |
| Estimation of the number of women living with metastatic breast cancer in the United States AB Mariotto, R Etzioni, M Hurlbert, L Penberthy, M Mayer Cancer Epidemiology and Prevention Biomarkers 26 (6), 809-815, 2017 | 493 | 2017 |
| Cancer survivors: a booming population C Parry, EE Kent, AB Mariotto, CM Alfano, JH Rowland Cancer Epidemiology and Prevention Biomarkers 20 (10), 1996-2005, 2011 | 492 | 2011 |
| Improved estimates of cancer-specific survival rates from population-based data N Howlader, LAG Ries, AB Mariotto, ME Reichman, J Ruhl, KA Cronin JNCI: Journal of the National Cancer Institute 102 (20), 1584-1598, 2010 | 488 | 2010 |
| Comparison of SEER treatment data with Medicare claims AM Noone, JL Lund, A Mariotto, K Cronin, T McNeel, D Deapen, ... Medical care 54 (9), e55, 2016 | 431 | 2016 |
| SEER Cancer Statistics Review, 1975–2007. National Cancer Institute; Bethesda, MD: 2010 SF Altekruse, CL Kosary, M Krapcho, N Neyman, R Aminou, W Waldron, ... | 412* | 2010 |
